Chiome Bioscience (株式会社カイオム・バイオサイエンス) is a company that researches and develops a drug discovery technology platform. Its proprietary ADLib system is used to generate the monoclonal antibodies for drug discovery research. The company also provides protein expression and purification, stable cell line generation, and Custom Antibody Generation services.